Söndag 20 April | 10:33:39 Europe / Stockholm

Kalender

Est. tid*
2025-08-29 07:00 Kvartalsrapport 2025-Q2
2025-04-25 N/A X-dag ordinarie utdelning TRMED 0.00 NOK
2025-04-24 N/A Årsstämma
2025-02-26 - Bokslutskommuniké 2024
2025-01-06 - Extra Bolagsstämma 2025
2024-08-30 - Kvartalsrapport 2024-Q2
2024-04-12 - X-dag ordinarie utdelning TRMED 0.00 NOK
2024-04-11 - Årsstämma
2024-02-28 - Bokslutskommuniké 2023
2023-08-31 - Kvartalsrapport 2023-Q2
2023-04-27 - X-dag ordinarie utdelning TRMED 0.00 NOK
2023-04-26 - Årsstämma
2023-02-28 - Bokslutskommuniké 2022
2022-08-31 - Kvartalsrapport 2022-Q2
2022-04-29 - X-dag ordinarie utdelning TRMED 0.00 NOK
2022-04-28 - Årsstämma
2022-03-01 - Bokslutskommuniké 2021
2021-11-18 - 15-10 2021-Q3
2021-08-26 - Kvartalsrapport 2021-Q2
2021-05-26 - Kvartalsrapport 2021-Q1
2021-04-28 - Årsstämma
2021-04-16 - X-dag ordinarie utdelning TRMED 0.00 NOK
2021-03-22 - Extra Bolagsstämma 2021
2021-02-18 - Bokslutskommuniké 2020
2020-11-19 - Kvartalsrapport 2020-Q3
2020-10-21 - Extra Bolagsstämma 2020
2020-08-27 - Kvartalsrapport 2020-Q2
2020-06-11 - X-dag ordinarie utdelning TRMED 0.00 NOK
2020-06-10 - Årsstämma
2020-05-26 - Kvartalsrapport 2020-Q1
2020-02-27 - Bokslutskommuniké 2019
2019-11-19 - Kvartalsrapport 2019-Q3
2019-08-22 - Kvartalsrapport 2019-Q2
2019-05-23 - Kvartalsrapport 2019-Q1
2019-04-26 - X-dag ordinarie utdelning TRMED 0.00 NOK
2019-04-25 - Årsstämma
2019-02-18 - Extra Bolagsstämma 2019
2018-08-22 - Kvartalsrapport 2018-Q2
2018-05-31 - X-dag ordinarie utdelning TRMED 0.00 NOK
2018-05-30 - Årsstämma
2018-05-30 - Kvartalsrapport 2018-Q1
2018-02-27 - Bokslutskommuniké 2017
2017-12-20 - Extra Bolagsstämma 2017
2017-11-22 - Kvartalsrapport 2017-Q3
2017-08-23 - Kvartalsrapport 2017-Q2
2017-05-26 - X-dag ordinarie utdelning TRMED 0.00 NOK
2017-05-24 - Årsstämma
2017-05-24 - Kvartalsrapport 2017-Q1
2017-02-28 - Bokslutskommuniké 2016
2016-11-23 - Kvartalsrapport 2016-Q3
2016-10-12 - Extra Bolagsstämma 2016
2016-08-24 - Kvartalsrapport 2016-Q2
2016-05-31 - Kapitalmarknadsdag 2016
2016-05-20 - X-dag ordinarie utdelning TRMED 0.00 NOK
2016-05-19 - Årsstämma
2016-05-19 - Kvartalsrapport 2016-Q1
2016-02-26 - Bokslutskommuniké 2015
2015-11-17 - Kapitalmarknadsdag 2015
2015-10-21 - Kvartalsrapport 2015-Q3
2015-08-26 - Kvartalsrapport 2015-Q2
2015-05-27 - Kvartalsrapport 2015-Q1
2015-03-09 - Årsstämma
2014-11-12 - Extra Bolagsstämma 2014

Beskrivning

LandNorge
ListaOB Match
SektorHälsovård
IndustriLäkemedel & Handel
Thor Medical är ett läkemedelsbolag. Bolaget specialiserar sig inom utveckling av antikroppsläkemedel för behandling utav hematologisk cancer. Störst specialisering återfinns inom precisionsterapi som används i den kliniska fasen. Övriga sjukdomar som behandlas är non-hodgkins lymfom (NHL). Bolaget grundades under 2009 och har sitt huvudkontor i Oslo, Norge.
2025-04-11 18:27:38
11.4.2025 18:27:35 CEST | Thor Medical ASA | Major shareholding notifications

Oslo, 11 April 2025

Ludvik Sandnes, Chairman of the Board at Thor Medical ASA (the "Company"), has
received proxies without voting instructions to vote for a total of 15,786,906
shares at the Company's Annual General Meeting on 24 April 2025, representing
approx. 5.00 percent of all shares in the Company. Additionally, Sandnes has
received proxies with voting instructions to vote for a total of 3,046,978
shares at the Company's Annual General Meeting on 24 April 2025, representing
approx. 0.97 percent of all shares in the Company.

Furthermore, Sandnes owns 626,489 shares, representing approx. 0.20 percent of
all shares issued in the Company, as well as 300,000 shares, representing
approx. 0.10 percent of all issued shares in the Company through Ekornhuset AS.
Sandnes will be able to cast votes at the Annual General Meeting for a total of
19,760,375 shares, representing approx. 6.27 percent of all issued shares in the
Company.

The received proxies are valid only for the aforementioned General Meeting and
will automatically expire, so that after the General Meeting, Sandnes will own
926,489 shares in the Company, including the shares owned by Ekornhuset AS.

This notification is issued because Sandnes has been granted proxies without
voting instructions for more than 5% of all voting rights in the Company. The
notification does not indicate that the aforementioned is the final number of
shares Sandnes will be able to vote for at the Annual General Meeting.

This information is subject to disclosure requirements pursuant to Section 4-2
of the Securities Trading Act.



ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18495673/5936/Download%20announce
ment%20as%20PDF.pdf